VANCOUVER, British Columbia, Feb. 23, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. The Company today reported financial results for the fourth quarter and full year ended December 31, 2011, and issued its financial guidance for 2012. Unless specified otherwise, all amounts are in U.S. dollars and in accordance with U.S. GAAP.
